Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Carlomagno

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|June 13, 2017
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell LicensingSimona Carlomagno, Michela Falco, Maria Bono, et al.
International Immunology|August 18, 2004
Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2Massimo Vitale, Simona Carlomagno, Michela Falco, et al.
Blood|August 12, 2006
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell functionMariella Della Chiesa, Simona Carlomagno, Guido Frumento, et al.
Journal of Clinical Medicine|October 19, 2019
NK Cell-Based Immunotherapy for Hematological MalignanciesSimona Sivori, Raffaella Meazza, Concetta Quintarelli, et al.
Journal of Leukocyte Biology|August 15, 2020
Natural killer cell impairment in ovarian clear cell carcinomaOrnella Patrizi, Fabio Rampinelli, Daniela Coltrini, et al.
Frontiers in Cell and Developmental Biology|March 13, 2020
miRNAs in NK Cell-Based Immune Responses and Cancer ImmunotherapySilvia Pesce, Marco Greppi, Elisa Ferretti, et al.
Cancers|December 16, 2020
Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors SurveillanceElisa Ferretti, Simona Carlomagno, Silvia Pesce, et al.
Frontiers in Immunology|October 5, 2020
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of CancerSimona Sivori, Mariella Della Chiesa, Simona Carlomagno, et al.
Frontiers in Immunology|July 13, 2023
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1Marco Greppi, Valentina Obino, Rayan Goda, et al.
Vaccines|July 27, 2022
NK Cell-Based Immunotherapy in Colorectal CancerMariella Della Chiesa, Chiara Setti, Chiara Giordano, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|June 13, 2017
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell LicensingSimona Carlomagno, Michela Falco, Maria Bono, et al.
International Immunology|August 18, 2004
Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2Massimo Vitale, Simona Carlomagno, Michela Falco, et al.
Blood|August 12, 2006
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell functionMariella Della Chiesa, Simona Carlomagno, Guido Frumento, et al.
Journal of Clinical Medicine|October 19, 2019
NK Cell-Based Immunotherapy for Hematological MalignanciesSimona Sivori, Raffaella Meazza, Concetta Quintarelli, et al.
Journal of Leukocyte Biology|August 15, 2020
Natural killer cell impairment in ovarian clear cell carcinomaOrnella Patrizi, Fabio Rampinelli, Daniela Coltrini, et al.
Frontiers in Cell and Developmental Biology|March 13, 2020
miRNAs in NK Cell-Based Immune Responses and Cancer ImmunotherapySilvia Pesce, Marco Greppi, Elisa Ferretti, et al.
Cancers|December 16, 2020
Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors SurveillanceElisa Ferretti, Simona Carlomagno, Silvia Pesce, et al.
Frontiers in Immunology|October 5, 2020
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of CancerSimona Sivori, Mariella Della Chiesa, Simona Carlomagno, et al.
Frontiers in Immunology|July 13, 2023
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1Marco Greppi, Valentina Obino, Rayan Goda, et al.
Vaccines|July 27, 2022
NK Cell-Based Immunotherapy in Colorectal CancerMariella Della Chiesa, Chiara Setti, Chiara Giordano, et al.
Pageof 4